JOHNSON & JOHNSON is 25.0x more valuable than UNITED THERAPEUTICS Corp by market capitalization ($579.83 B vs $23.17 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | UTHR | JNJ |
|---|---|---|
| Market cap | $23.17 B | $579.83 B |
| US-listed rank | #563 | #20 |
| Revenue (latest FY) | $3.18B | $94.19B |
| Net income (latest FY) | $1.33B | $26.80B |
| Net margin | 41.9% | 28.5% |
| P/E (trailing FY) | 17.4 | 21.6 |
| SEC filings | 4,203 | 984 |
JOHNSON & JOHNSON is 25.0x more valuable than UNITED THERAPEUTICS Corp by market capitalization ($579.83 B vs $23.17 B).
In their latest fiscal years, UNITED THERAPEUTICS Corp reported $3.18B in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: UNITED THERAPEUTICS Corp and JOHNSON & JOHNSON, or browse the full rankings.